The freeze has impacted the funding of most continuing grants at NIH. These grants fund ongoing research, including many studies involving human subjects in clinical trials. Since Congress provides funding annually, these grants must be extended each year, but it is normally a routine administrative process.

Freezing this funding to implement the administration’s DEI policies does not comply with the federal court’s TRO. It also jeopardizes critical research on cancer treatments, heart disease prevention, stroke intervention, and other potentially life-saving topics.

David Moorman, a brain researcher and professor at the University of Massachusetts-Amherst, has not had his annual grant renewed. It is now three weeks late. “At some point, our money will run out and if it doesn’t get renewed, we will have to start firing people in my lab and this research will die,” Moorman told the Boston Globe.